Partnerships for Screening and Reprofiling

Using our extensive portfolio of disease models and toxicity assays, we offer partnerships for library screening and reprofiling.

Library Screening: For library screening, toxic compounds can be rapidly eliminated. Non toxic compounds can then be rapidly assessed in numerous disease models.

Disease Models and Reprofiling: Some assays including angiogenesis, apoptosis, choroidal neovascularization, xenotransplant, glial fibrillary acidic protein, tyrosine kinases, can be performed using high throughput microplate formats.

Partnerships can be structured as cost sharing, exclusive research agreements, or joint ventures. For more information, fill out our contact form.

<<Back to Home Page


We offer a number of microplate-based whole animal disease models for drug screening.

Learn more